CorMedix Inc.
CRMD
$10.32
$0.545.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 162.41% | 1.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 162.41% | 1.68% | |||
| Cost of Revenue | 306.26% | 16.64% | |||
| Gross Profit | 155.34% | 1.04% | |||
| SG&A Expenses | 130.59% | 12.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 162.11% | 6.52% | |||
| Operating Income | 162.73% | -2.89% | |||
| Income Before Tax | 158.37% | -1.43% | |||
| Income Tax Expenses | -10,835.72% | -- | |||
| Earnings from Continuing Operations | 447.52% | -3.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 447.52% | -3.95% | |||
| EBIT | 162.73% | -2.89% | |||
| EBITDA | 179.79% | -2.86% | |||
| EPS Basic | 389.83% | -7.74% | |||
| Normalized Basic EPS | 128.15% | -5.36% | |||
| EPS Diluted | 350.00% | -6.67% | |||
| Normalized Diluted EPS | 112.73% | -5.51% | |||
| Average Basic Shares Outstanding | 11.78% | 4.11% | |||
| Average Diluted Shares Outstanding | 19.88% | 4.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||